Early detection of liver tumors in initial stages Monitoring high-risk patients with liver cirrhosis Providing accurate diagnosis for better clinical outcomes

Patients with confirmed liver cirrhosis Individuals with chronic Hepatitis B or C infections People with a strong family history of liver cancer

Blood sample collection for AFP biomarker testing Detailed abdominal ultrasound imaging of the liver Expert review of results by a specialist consultant

Book HCC Surveillance Program | Lahalak Medical Platform

A comprehensive medical protocol designed for early detection of liver tumors using advanced biomarkers and imaging, significantly improving treatment outcomes and long-term liver health preservation for high-risk patients.

Scientific name: Hepatocellular Carcinoma (HCC) Surveillance Program

This program includes Alpha-Fetoprotein (AFP) blood testing combined with abdominal ultrasound to monitor liver health and detect abnormal changes early, ensuring optimal clinical intervention and management.

Hepatocellular Carcinoma (HCC) Surveillance Program - Protect Your Liver: Early Screening

Service type Preventive screening program

Duration 45-60 minutes

Fasting 8-12 hours of fasting

Included Services

Alpha-Fetoprotein (AFP) Test
Abdominal Ultrasound
Specialist Consultation

Medical Service Information

Program Objectives

Early detection of liver tumors in initial stages
Monitoring high-risk patients with liver cirrhosis
Providing accurate diagnosis for better clinical outcomes

Target Groups

Patients with confirmed liver cirrhosis
Individuals with chronic Hepatitis B or C infections
People with a strong family history of liver cancer

Screening Process

Blood sample collection for AFP biomarker testing
Detailed abdominal ultrasound imaging of the liver
Expert review of results by a specialist consultant

Conditions & Notices

Fasting for at least 8 hours
Provide previous medical reports if available